IL6 and COVID-19: Additionally, GI tract microbial dysbiosis and an increase in LPS-binding protein (LBP) were observed in severe COVID-19 patients over those with mild COVID-19, with LBP correlating to other inflammatory markers such as C-reactive protein (CRP) and IL-6 (220).